The government will end the 18-month-long outdoor mask mandate following Monday, Prime Minister Kim Boo-kyum said.However, Koreans will have to wear a mask at gatherings, performances, and sports events where more than 50 people gather because these places have a high risk of infection. The governme
A government official said Korea’s first homegrown digital therapeutic would get marketing approval within this year.Kang Young-kyu, director of the Digital Health Devices Division at the Ministry of Food and Drug Safety (MFDS), said 10 digital therapeutics (DTx) were in clinical trials. At least on
Vivozon Pharmaceuticals said that it has received a final administrative disposition from the Ministry of Food and Drug Safety for 26 drug manufacturing violations.The regulatory disposition comes after the ministry suspended the making and selling of products made by Vivozon and ordered their recal
Daewoong Pharmaceutical said it signed a license-out and cooperation contract with AstraZeneca Korea for Crezet, its hyperlipidemia treatment, in four Asian countries -- Indonesia, Thailand, Malaysia, and the Philippines.Under the accord, the two companies plan to apply for local licenses for Crezet
Novo Nordisk is seeking to replace the existing glucagon-like peptide-1 (GLP-1) receptor agonist (RA) with a second-generation drug, semaglutide, to fight diabetes and obesity in Korea.On Thursday, the Ministry of Food and Drug Safety authorized the use of Novo Nordisk’s Ozempic to treat adults with
The Korean regulator is likely to authorize PCL’s saliva-based Covid-19 test device soon, industry sources said.On Friday, sources from the medical community and the medical device industry said that PCL, a Korean in vitro diagnostic device manufacturer, was expected to win the Ministry of Food and
Seoul National University Hospital and Seoul Medical University will start developing a portable hemodialysis device and filter together with HealthConnect, Synopex, and Bayada Home Health Care.Hemodialysis, which accounts for more than 80 percent of all renal replacement therapies, is a treatment t
The conflict between President Moon Jae-in and President-elect Yoon Suk-yeol continues 12 days before the new government's inauguration.The problem is that it is not only political conflicts between the two administrations but also the ongoing proxy war regarding the current quarantine policies.Yoon
A survey showed that both the general public and experts agreed on the need to establish a special government agency to enhance research and development (R & R&D) in the health sector.The Korea Health Industry Development Institute (KHIDI) on Tuesday released the results of a survey on whether Korea
LG Chem said that it has signed a local joint sales contract with Kyowa Kirin Korea for Nesp and Regpara, its chronic kidney disease (CKD) treatments.Under the accord, LG Chem will operate at the clinic and hospital level, while Kyowa Kirin Korea will operate at the general hospital level.LG Chem pl
Samsung Biologics said that it achieved the highest quarterly performance ever in the first quarter by posting 511.3 billion won ($401.6 million) in sales in the first quarter of this year, up 96 percent from the same period in 2021.The company also registered 176.4 billion won in operating profit,
Over 95 percent of the Korean medical community opposed telemedicine in 2014, but the proportion recently went down to about 65 percent, a survey showed.The Korean Medical Association’s (KMA) Healthcare Policy Research Institute conducted an online poll on 955 KMA-member physicians from March 14-16.
Daewoong Pharmaceutical said it signed an agreement with UCI Therapeutics, a CAR-NK cell treatment developer, to conduct joint research on immune cell therapy on Tuesday.Under the agreement, the two companies will cooperate in developing immune cell therapy based on their cell therapy development an
Helixmith said it has signed a three-party memorandum of understanding with Cartexell and GI Cell for joint research on cell gene therapy products.The trilateral MOU will encourage cooperation between the three companies to identify candidate materials for cell gene therapy and cooperate in manufact
Korea is regarded as one of the most “hip” countries. The popularity of K-pop, K-drama, K-movie, K-food, and even K-beauty is growing worldwide.This is more surprising because the nation was in a war 70 years ago and one of the poorest countries 60 years ago.The term “Miracle on the Han River,” refe
Researchers at Seoul National University Hospital have developed a simple method to predict the risk of heart failure in patients with hypertrophic cardiomyopathy.According to the hospital, people with hypertrophic cardiomyopathy need to take special care as it can lead to end-stage heart failure. H
President-elect Yoon Suk-yeol's transition committee said Wednesday that the new government would determine whether to remove the outdoor mask mandate toward the end of May.The transition team also said it plans to secure hospital beds and manpower to prepare for a possible resurge of Covid-19, prep
Labor union members of Sanofi Aventis Korea, the offshoot of the French-based multinational pharmaceutical company, have filed a lawsuit against the company's general manager and human resources head for failing to pay overtime allowances.The union filed a lawsuit on behalf of four of its members on
AT Sens said that it has signed a contract with Al Dabbous Medical Company, a Kuwait-based medical device distributor, to export AT-Patch, a continuous, long-term use electrocardiogram (ECG) device.Under the accord, AT Sens will export about 3 billion won ($2.4 million) worth of AT-Patch to Al Dabbo
Celltrion said that it recently completed a patent agreement with AbbVie, the developer of the blockbuster autoimmune disease treatment Humira (Ingredient: adalimumab), and will start selling its biosimilar version, Yuflyma, in the U.S. from July 2023.Celltrion applied Yuflyma to the U.S. Food and D